Platelet Sub-study of the Neomindset Trial

NCT05767723 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
DRUG: Monotherapy: Ticagrelor alone OR Prasugrel alone

Sponsor

Hospital Israelita Albert Einstein